"Our API (active pharmaceutical ingredient) unit in Rajasthan being set up at an investment of about Rs 100 crore will be functional by end of this year and boost manufacture of affordable drugs," Mankind Pharma Chairman R C Juneja told PTI here.
Indian pharmaceutical industry is worth Rs 1.20 lakh crore, of which the API contributes about Rs 50,000-55,000 crore, the company said.
Out of 10,000 manufacturers, about 70 per cent do drug formulation while the rest 30 per cent manufacture APIs, in which Mankind Pharma is a leader.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
